Skip to main content
OpenTrials

Clinical trial condition

Epilepsy

Explore clinical trials studying Epilepsy. Study availability and eligibility vary by location and protocol.

1,346 public trials 232 recruiting studies
Refine in advanced search Browse all conditions

Epilepsy trial results

Completed

Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy

NCT03222349

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +1 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • NW FL Clinical Research Group, LLC Gulf Breeze, Florida, United States
  • Children's St. Peters University Hospital New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

NCT00988429

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • University of South Alabama Department of Neurology Mobile, Alabama, United States
  • Neurology Clinic, P.C. Northport, Alabama, United States
  • 21st Century Neurology - Division of Xenoscience, Inc. Phoenix, Arizona, United States
  • Barrow Neurological Institute / St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 162 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

NCT03685630

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +2 more
Locations
  • Ep0118 116 Asaka, Japan
  • Ep0118 126 Bunkyō City, Japan
  • Ep0118 111 Hamamatsu, Japan
  • Ep0118 121 Itami, Japan
View Trial Details
Completed

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

NCT02856802

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Site 30 San Diego, California, United States
  • Site 11 Santa Monica, California, United States
  • Site 31 Boston, Massachusetts, United States
  • Site 18 Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

NCT03836924

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +6 more
Locations
  • BGS Gleneagles Global Hospitals Bengaluru, Karnataka, India
  • Seth G S Medical College & KEM Hospital Mumbai, Maharashtra, India
  • Brain Clinic, Jasleen Hospital Nagpur, Maharashtra, India
  • Getwell Hospital and Research Institute Nagpur, Maharashtra, India
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details

Related conditions